Printer Friendly
The Free Library
14,650,817 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Noven Announces 2006 Earnings Release Date and Upcoming Investor Conference Presentation.


MIAMI Miami, cities, United States
Miami (mīăm`ē, –ə).

1 City (1990 pop. 358,548), seat of Dade co., SE Fla., on Biscayne Bay at the mouth of the Miami River; inc. 1896.
 -- Noven Pharmaceuticals, Inc. (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:NOVN) today announced its 2006 earnings release date as well as a scheduled investor conference presentation.

On March 1, after the close of the U.S. market, Noven is scheduled to issue a press release announcing its financial results for the quarter and year ended December 31, 2006. At 5:00 p.m. Eastern Time the same day, a conference call among management and analysts will be broadcast live via the Internet at www.noven.com, and thereafter a rebroadcast will be accessible at the same site for at least two weeks. A taped replay of the call will be available beginning the evening of March 1 through March 3 by calling 877-660-6853 (from within the U.S.) or 201-612-7415 (from outside the U.S.) and entering account number 286 and conference ID number 228057.

Noven also announced that Robert C. Strauss, its President, CEO (1) (Chief Executive Officer) The highest individual in command of an organization. Typically the president of the company, the CEO reports to the Chairman of the Board.  & Chairman, is scheduled to provide an update on Noven's business and prospects at the Raymond James This article or section is written like an .
Please help [ rewrite this article] from a neutral point of view.
Mark blatant advertising for , using .
 28th Annual Institutional Investors Conference in Orlando on Wednesday, March 7, 2007, at 8:05 a.m. Eastern Time. The public is invited to listen to the presentation live via webcast at www.noven.com, and a replay will be available for at least two weeks at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida “Miami” redirects here. For the Native American tribe, see Miami tribe.

Miami is a major city in southeastern Florida, in the United States. It is the county seat of Miami-Dade County. Miami is a gamma world city with an estimated population of 404,048.
, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven's prescription patches are approved in over 30 countries and include Vivelle-Dot[TM] (the most prescribed estrogen patch The estrogen patch is a delivery system for estradiol used as hormone replacement therapy to treat the symptoms of menopause, such as hot flashes and vaginal dryness, and to prevent osteoporosis.  in the U.S.) and Daytrana[TM] (the first and only patch approved for the treatment of ADHD Attention-Deficit/Hyperactivity Disorder (ADHD) Definition

Attention-deficit/hyperactivity disorder (ADHD) is a developmental disorder characterized by distractibility, hyperactivity, impulsive behaviors, and the inability to remain focused on tasks or
). A range of new patches is under development by Noven in collaboration with industry partners. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.
COPYRIGHT 2007 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2007, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Date:Feb 22, 2007
Words:314
Previous Article:Cabela's Inc. Reports Record Results for Fourth Quarter and Fiscal 2006 Year End.(Financial report)
Next Article:Endurance Specialty Holdings Declares Quarterly Dividend of $0.484375 Per Series A Preferred Share.
Topics:



Related Articles
Noven to Announce 2000 First Quarter Results On May 3.
Noven to Announce 2000 Financial Results On February 26.
Noven to Announce First Quarter 2001 Financial Results On April 30; Public Invited to Listen to Earnings Conference Call via Internet.
Noven to Announce 2001 Financial Results on February 26; Public Invited to Listen to Earnings Conference Call Via Internet.
Noven to Announce 2002 First Quarter Financial Results on April 30; Public Invited to Listen to Earnings Conference Call Via Internet.
Noven to Announce First Quarter Financial Results on April 30; Public Invited to Listen to Earnings Conference Call Via Internet.
Noven Announces Earnings Release Date and Upcoming Investor Conference Presentation.
Noven Announces Earnings Release Date and Upcoming Investor Conference Presentation.
Noven Pharmaceuticals to Present at Upcoming Investor Conferences.
Noven Reports Third Quarter 2006 Financial Results.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles